Home Compare JAZZ vs VTRS
Stock Comparison · Single-driver result

Jazz Pharmaceuticals vs Viatris: Which Stock Looks Stronger in 2026?

Structurally, Jazz Pharmaceuticals and Viatris are closely matched — neither holds a meaningful edge overall. Viatris still has the edge on stability, which keeps the comparison from looking entirely one-sided. The market setup is broadly comparable for both — no clear directional signal from price behavior. The market is not adding a decisive signal either way — the structural read carries the weight.

The comparison is based on similar long-term financial trajectories, not sector labels. Both peer scores are relative to the Russell 1000 universe, making them directly comparable.

Updated 2026-08-16

The page question resolves more clearly through growth, even though the overall score is effectively tied.

Trajectory Similarity
0.66
Moderately similar
Peer-set rank: #11
within Jazz Pharmaceuticals plc's functional peer set

This comparison is anchored in long-term financial trajectory similarity within the selected peer universe.

A moderate similarity means the pair is structurally comparable, but not a near-twin trajectory match.

The strongest overlap appears in investment intensity and revenue stability.

Similarity drivers
investment intensityrevenue stability
How to read the score
0.85–1.00 · Very similar0.70–0.84 · Similar0.55–0.69 · Moderately similarbelow 0.55 · Loose match
Peer-Relative Score
JAZZ
Jazz Pharmaceuticals plc
66
Peer-Score
Signal qualitylow
Peer basis: Russell 1000
vs
VTRS
Viatris Inc.
66
Peer-Score
Signal qualitylow
Peer basis: Russell 1000

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

The clearest separation appears in growth.

Dimension spread: JAZZ vs VTRS Profitability 38 43 Stability 50 77 Valuation 82 88 Growth 100 56 JAZZ VTRS
Gap Ranking
#1 Growth +44
#2 Stability +27
#3 Valuation +6
#4 Profitability +5
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for JAZZ and VTRS Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer JAZZVTRS Relative valuation Structural strength

Viatris Inc. and Jazz Pharmaceuticals plc look relatively close on structure, but the price setup still leans toward Viatris Inc..

Valuation position uses peer-relative PE percentile (idx_pct_pe) and Forward P/E where available.

Entry today — historical context

Where JAZZ and VTRS each sit in their own 5-year price and valuation history.

BASED ON 5-YEAR HISTORY JAZZ Elevated · above norm 0th 50th 100th 3 pct gap VTRS Elevated · above norm 0th 50th 100th 98th 95th
JAZZ (98th percentile) and VTRS (95th percentile) both sit in the upper portion of their own 5-year ranges. The historical entry context is broadly similar for both. This reflects entry timing, not which company is structurally stronger.

Describes historical entry positioning only. Descriptive — not investment advice.

Relative Position vs Comparable Companies
Growth
Both rank well on growth, but Jazz Pharmaceuticals plc still holds a clear edge.
Stability
On stability, the edge still sits with Viatris Inc., even though both profiles look solid.
Growth — Dominant Gap
JAZZ
100
VTRS
56
Gap+44in favour of JAZZ

The current lead is backed by a stronger multi-year growth trajectory.

What keeps the gap from being one-sided

Stability still leans toward Viatris Inc., so the lead is real without reading as one-way.

What this means for the comparison

Growth provides the clearer read here, while the broader score remains level.

Explore full peer positioning in AssetNext

Break down the JAZZ vs VTRS comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Other comparisons with conflicting dimension signals

Explore how JAZZ and VTRS each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Because scores are peer-relative, the same company can have slightly different scores in different index universes. On comparison pages, both companies are shown within their shared peer universe wherever possible — so the scores are directly comparable. The peer basis is stated on each score card.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.